Breaking News

TRYP Therapeutics Inc (TRYP)

CSE

Add to/Remove from Watchlist Add to Watchlist

TRYP Therapeutics historical data, for real-time data please try another search

0.06 0.00 0.00%

29/04 - Delayed Data. Currency in CAD ( Disclaimer )

Type: Equity

Market: Canada

Volume: 0
Bid/Ask: 0.06 / 0.07
Day's Range: 0.06 - 0.06

General
Chart
- Streaming Chart
- Interactive Chart
Financials
Technical
Forum

Discussions
Recent Sentiments
User Rankings

TRYP Recent Sentiments

This page contains information on users’ sentiments for the TRYP Therapeutics Inc stock, which are displayed both on charts of different periods of time and on a detailed table.

Start Date	Username	Open Rate	End Date	Chg. %
Jun 30, 2022	BRC BTTHMMR	0.11	Jul 04, 2022 @ 0.08	-27.27%
Nov 05, 2021	Sh Park	0.34	Nov 26, 2021 @ 0.30	-11.76%
Oct 15, 2021	Вадим Артёмов	0.39	Oct 18, 2021 @ 0.39	0.00%
Jul 27, 2021	David Pelletier	0.59	Aug 02, 2021 @ 0.61	+3.39%
Jun 28, 2021	Tobias Källqvist	0.54	Jul 23, 2021 @ 0.53	-1.85%
Jun 01, 2021	Sh Park	0.66	Jun 25, 2021 @ 0.55	-16.67%
May 13, 2021	Rose Yane	0.70	May 17, 2021 @ 0.67	+4.29%
Mar 04, 2021	Sh Park	0.73	Mar 26, 2021 @ 0.68	-6.85%
Mar 03, 2021	Tobias Källqvist	0.88	Mar 26, 2021 @ 0.68	-22.73%
Feb 17, 2021	Van Harned	1.15	Mar 12, 2021 @ 0.88	-23.48%
Feb 17, 2021	Wolfgang Mőller	1.17	Mar 12, 2021 @ 0.88	-24.79%
Feb 16, 2021	Andreas Schatz	1.13	Mar 12, 2021 @ 0.88	-22.12%
Feb 16, 2021	Sebastian Botero	1.14	Mar 12, 2021 @ 0.88	-22.81%
Feb 08, 2021	Patrick Fitzgerald	1.10	Mar 05, 2021 @ 0.79	-28.18%
Feb 02, 2021	Önder Güngör	0.69	Feb 26, 2021 @ 0.87	+26.09%
Jan 28, 2021	Martin Gervais	0.60	Feb 19, 2021 @ 1.07	+78.33%
Jan 27, 2021	Sh Park	0.61	Feb 19, 2021 @ 1.07	+75.41%
Jan 18, 2021	Sebastian Botero	0.70	Feb 12, 2021 @ 0.99	+41.43%
Jan 13, 2021	Sh Park	0.56	Jan 27, 2021 @ 0.62	+10.71%

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

I Agree

TRYP Comments

Write your thoughts about TRYP Therapeutics Inc

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Matty Silverstoone Jul 23, 2021 12:23PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

By targeting the 505 b2 and the orphan drug design, $TRYP is granted the "Orphan Drug Status", meaning that they receive much shorter review wait times, federal tax credit for clinical trials, and direct written recommendation from the FDA on the trials. They are working to get their psilocybin treatments approved by the FDA and on the market, and recently announced plans for a Phase 2a clinical trial to evaluate the efficacy of TRYP-8802 for treating Fibromyalgia with the University of Michigan. This is one to watch!

0 0

Report

Stock Hawk Jul 15, 2021 3:52PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Tryp Therapeutics ( $TRYP ) is a pharmaceutical company focused on developing psilocybin-based compounds. One of their products is in phase 2 of clinical trials to see if it helps fibromyalgia and eating disorder patients. Additionally, they are trying to develop synthetic psilocybin.Today $TRYP.CN announced that they will host their Q3 Investor Day, online, on July 29 at 9:00am PSTDuring this event, Tryp's management team will discuss updates on their synthetic psilocybin programThere will also be a Q&A session with the company's leaders including the CEO, CFO, and PresidentTheir CEO, Greg McKee, stated that he was excited to showcase the research that Tryp has been doing in collaboration with the University of Michigan, the University of Florida, and other academic partnersMore here, as well as a link to register for the event: https://ceo.ca/@newsfile/tryp-therapeutics-to-host-q3-investor-day-on-july-29

0 0

Report

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="228353087">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="228353087" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="228353087" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="228353087">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

US 30	39,909.0	+350.9	+0.89%
US 500	5,308.2	+61.5	+1.17%
Dow Jones	39,911.10	+352.99	+0.89%
S&P 500	5,308.60	+61.92	+1.18%
Nasdaq	16,744.03	+232.85	+1.41%
S&P 500 VIX	12.41	-1.01	-7.53%
Dollar Index	104.200	-0.692	-0.66%

Crude Oil WTI	78.90	+0.88	+1.13%
Brent Oil	82.97	+0.59	+0.72%
Natural Gas	2.407	+0.063	+2.69%
Gold	2,392.00	+32.10	+1.36%
Silver	29.945	+1.243	+4.33%
Copper	4.9220	+0.0270	+0.55%
US Soybeans	1,214.25	-0.25	-0.02%

U.S. 10Y	4.353	-0.093	-2.09%
U.S. 30Y	4.515	-0.078	-1.70%
U.S. 5Y	4.357	-0.101	-2.26%
U.S. 3M	5.404	+0.000	+0.00%
US 10Y T-Note	109.69	+0.59	+0.54%
Euro Bund	131.78	+1.17	+0.90%
10-2 Yield Spread	-36.05	-1.76	5.13%

Apple	189.70	+2.27	+1.21%
Alphabet A	172.51	+2.17	+1.27%
Tesla	173.98	-3.57	-2.01%
Amazon.com	186.03	-1.04	-0.56%
Netflix	613.15	-0.51	-0.08%
Meta Platforms	481.66	+9.81	+2.08%
Bank of America	38.93	+0.44	+1.14%

Recent Quotes

	Name	Price	Chg.	Chg. %
	TRYP	0.06	0.00	0.00%
	BA	158.460	0.000	0.00%

Market Movers

Name	Last	Chg. %	Vol.
GME	39.95	-18.04%	125.36M
TSLA	174.00	-2.00%	74.21M
AMZN	186.01	-0.57%	69.28M
AAPL	189.66	+1.19%	56.21M
AMD	159.48	+4.12%	38.59M
MSFT	423.18	+1.77%	14.65M
BRKa	623,975	+0.76%	13.72K

Name	Last	Chg. %	Vol.
SMCI	951.55	+15.71%	9.39M
DHI	157.67	+6.53%	3.09M
MKTX	216.77	+6.04%	652.90K
NOW	760.68	+5.41%	1.26M
LEN	171.05	+5.37%	2.05M
IDXX	548.13	+5.19%	682.10K
PHM	122.01	+5.02%	2.40M

Name	Last	Chg. %	Vol.
ALB	127.72	-5.71%	3.49M
WBD	8.21	-4.15%	28.63M
SIRI	3.040	-4.10%	18.49M
FMC	64.00	-3.43%	2.13M
WBA	17.85	-2.70%	6.58M
HAS	60.55	-2.63%	1.54M
BFb	47.59	-2.51%	1.56M